Percutaneous osteoplasty and interventions in VBCF (2023 – CME) – online course
Description
Authors: X. Buy, R. Cazzato and P. Lohle
Reviewers: M. Husainy, J. Del Cura Rodriguez, D. Filippiadis, J. Garnon and C. Nice
This course corresponds to chapters 2.2.4.2 Percutaneous ablation of bone and soft tissue lesions, 2.2.4.4 Percutaneous osteoplasty and 2.2.4.5.1 Interventions in vertebral body compression fractures (VBCF) in the European Curriculum and Syllabus for IR.
Abstract
Percutaneous vertebroplasty is applied for the treatment of benign osteoporotic or malignant osteolytic vertebral body fractures. The procedure relies on poly(methyl methacrylate) (PMMA) injection inside the vertebral body in order to consolidate the fracture, achieve effective pain control, and prevent further vertebral collapse. The aim of this course is to present the indications and contraindications of percutaneous vertebroplasty and describe the technique and the devices that are commonly used.
Learning objectives
- Learn the basics of percutaneous vertebral augmentation.
- Learn the indications and contraindications of percutaneous treatment in benign and malignant vertebral compression fractures (VCFs).
- Learn about the correct material needed for percutaneous vertebroplasty.
- Learn about the percutaneous vertebral approach at cervical, thoracic, lumbar and sacral levels.
- Learn how to avoid complications.
Further information
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapters 2.2.4.2 Percutaneous ablation of bone and soft tissue lesions, 2.2.4.4 Percutaneous osteoplasty and 2.2.4.5.1 Interventions in vertebral body compression fractures (VBCF).
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC). The CME accreditation for this course will expire on March 30, 2025. A non-CME accredited version of the course will remain available for two more years
The acquired CME Certificate will be available in the myCIRSE area under CIRSE Academy.
The enrolment period of this course is linked to the validity of the All-Access Pass.
Release date: March 2023
